Apixaban Versus Dual-antiplatelet Therapy (Clopidogrel and Aspirin) in Acute Non-disabling Cerebrovascular Events

Clinical trial NCT01924325 · UNKNOWN

Trial details

NCT number: NCT01924325
Sponsor: Xijing Hospital
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Ischemic Stroke TIA

Start date: 2014-01-01
Primary completion: 2015-12-01
Enrollment: 10000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.